218Indexed trials
mesh condition
Dementia
Intelligence
Dementia intelligence: 218 indexed trials, 43 recruiting studies, 174 sponsors across 49 countries.
43Recruiting
174Sponsors
49Countries
Leading sponsors
Massachusetts General Hospital51 recruiting
Washington University School of Medicine53 recruiting
University of California, Los Angeles40 recruiting
Johns Hopkins University33 recruiting
Emory University30 recruiting
Chinese University of Hong Kong30 recruiting
The University of Hong Kong32 recruiting
Radboud University Medical Center30 recruiting
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.20 recruiting
Janssen Research & Development, LLC20 recruiting
Columbia University20 recruiting
Hopeful Aging20 recruiting
Geographic activity
United States104trials
France22trials
Canada22trials
United Kingdom18trials
Spain13trials
Italy13trials
Netherlands12trials
Australia11trials
Germany10trials
Hong Kong7trials
South Korea6trials
Belgium5trials
Leading interventions
Donepezil5trials
Escitalopram3trials
SAFE at Home2trials
Neuroimaging2trials
Usual Care2trials
galantamine hydrobromide2trials
E20202trials
Placebo Oral Tablet2trials
Exercise2trials
Music2trials
A combination of various test and biomarkers will be completed to understand the effect of hypertensive disorders of pregnancy in brain health in midlife.1trials
ACI-24.060 at Dose A in Study Part 21trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.